Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.
National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Eur J Med Res. 2023 Jul 3;28(1):216. doi: 10.1186/s40001-023-01174-8.
Polycystic ovary syndrome (PCOS) women have high incidences of dyslipidemia, obesity, impaired glucose tolerance (IGT), diabetes, and insulin resistance (IR) and are fragile to female infertility. Obesity and dyslipidemia may be the intermediate biological mechanism for the associations between glucose metabolism dysfunction and abnormal oogenesis and embryogenesis.
This retrospective cohort study was performed at a university-affiliated reproductive center. A total of 917 PCOS women aged between 20 and 45 undergoing their first IVF/ICSI embryo transfer cycles from January 2018 to December 2020 were involved. Associations between glucose metabolism indicators, adiposity and lipid metabolism indicators, and IVF/ICSI outcomes were explored using multivariable generalized linear models. Mediation analyses were further performed to examine the potential mediation role of adiposity and lipid metabolism indicators.
Significant dose-dependent relationships were found between glucose metabolism indicators and IVF/ICSI early reproductive outcomes and between glucose metabolism indicators and adiposity and lipid metabolism indicators (all P < 0.05). Also, we found significant dose-dependent relationships between adiposity and lipid metabolism indicators and IVF/ICSI early reproductive outcomes (all P < 0.05). The mediation analysis indicated that elevated FPG, 2hPG, FPI, 2hPI, HbA1c, and HOMA2-IR were significantly associated with decreased retrieved oocyte count, MII oocyte count, normally fertilized zygote count, normally cleaved embryo count, high-quality embryo count, or blastocyst formation count after controlling for adiposity and lipid metabolism indicators. Serum TG mediated 6.0-31.0% of the associations; serum TC mediated 6.1-10.8% of the associations; serum HDL-C mediated 9.4-43.6% of the associations; serum LDL-C mediated 4.2-18.2% of the associations; and BMI mediated 26.7-97.7% of the associations.
Adiposity and lipid metabolism indicators (i.e., serum TG, serum TC, serum HDL-C, serum LDL-C, and BMI) are significant mediators of the effect of glucose metabolism indicators on IVF/ICSI early reproductive outcomes in PCOS women, indicating the importance of preconception glucose and lipid management and the dynamic equilibrium of glucose and lipid metabolism in PCOS women.
多囊卵巢综合征(PCOS)女性的血脂异常、肥胖、葡萄糖耐量受损(IGT)、糖尿病和胰岛素抵抗(IR)发生率较高,且易发生女性不孕。肥胖和血脂异常可能是葡萄糖代谢功能障碍与异常卵子发生和胚胎发生之间关联的中间生物学机制。
这是一项在大学附属医院生殖中心进行的回顾性队列研究。共纳入 917 名年龄在 20 至 45 岁之间的 PCOS 女性,她们均于 2018 年 1 月至 2020 年 12 月期间首次进行体外受精/卵胞浆内单精子注射(IVF/ICSI)胚胎移植周期。采用多变量广义线性模型探讨葡萄糖代谢指标、体脂和血脂代谢指标与 IVF/ICSI 结局之间的相关性。进一步进行中介分析以检验体脂和血脂代谢指标的潜在中介作用。
葡萄糖代谢指标与 IVF/ICSI 早期生殖结局之间存在显著的剂量依赖性关系,与体脂和血脂代谢指标之间也存在显著的剂量依赖性关系(均 P<0.05)。此外,我们发现体脂和血脂代谢指标与 IVF/ICSI 早期生殖结局之间也存在显著的剂量依赖性关系(均 P<0.05)。中介分析表明,在控制体脂和血脂代谢指标后,升高的 FPG、2hPG、FPI、2hPI、HbA1c 和 HOMA2-IR 与获卵数、MII 卵母细胞数、正常受精胚胎数、正常分裂胚胎数、优质胚胎数或囊胚形成数减少显著相关。血清 TG 介导了 6.0%至 31.0%的关联;血清 TC 介导了 6.1%至 10.8%的关联;血清 HDL-C 介导了 9.4%至 43.6%的关联;血清 LDL-C 介导了 4.2%至 18.2%的关联;而 BMI 则介导了 26.7%至 97.7%的关联。
体脂和血脂代谢指标(即血清 TG、血清 TC、血清 HDL-C、血清 LDL-C 和 BMI)是葡萄糖代谢指标对 PCOS 女性 IVF/ICSI 早期生殖结局影响的重要中介,这表明 PCOS 女性在受孕前进行血糖和血脂管理以及维持血糖和血脂代谢的动态平衡非常重要。